Executive summary of the 11th HHT international scientific conference

Helen Arthur, Urban Geisthoff, James R. Gossage, Christopher C.W. Hughes, Pascal Lacombe, Mary E. Meek, Paul Oh, Beth L. Roman, Scott O. Trerotola, Sebastiaan Velthuis, Whitney Wooderchak-Donahue

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Hereditary hemorrhagic telangiectasia (HHT) is a hereditary condition that results in vascular malformations throughout the body, which have a proclivity to rupture and bleed. HHT has a worldwide incidence of about 1:5000 and approximately 80 % of cases are due to mutations in ENG, ALK1 (aka activin receptor-like kinase 1 or ACVRL1) and SMAD4. Over 200 international clinicians and scientists met at Captiva Island, Florida from June 11–June 14, 2015 to present and discuss the latest research on HHT. 156 abstracts were accepted to the meeting and 60 were selected for oral presentations. The first two sections of this article present summaries of the basic science and clinical talks. Here we have summarized talks covering key themes, focusing on areas of agreement, disagreement, and unanswered questions. The final four sections summarize discussions in the Workshops, which were theme-based topical discussions led by two moderators. We hope this overview will educate as well as inspire those within the field and from outside, who have an interest in the science and treatment of HHT.

Original languageEnglish (US)
Pages (from-to)511-524
Number of pages14
Issue number4
StatePublished - Oct 1 2015


  • ALK1
  • Arteriovenous malformation
  • Endoglin
  • Epistaxis
  • HHT
  • Hereditary hemorrhagic telangiectasia

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cancer Research


Dive into the research topics of 'Executive summary of the 11th HHT international scientific conference'. Together they form a unique fingerprint.

Cite this